Skip to main content
Erschienen in: Urolithiasis 6/2004

01.12.2004 | Original Paper

Clinical features determining the fate of a long-term, indwelling, forgotten double J stents

verfasst von: Kwanjin Park, Seong-Soo Jeon, Hyungkeun Park, Hyeon Hoe Kim

Erschienen in: Urolithiasis | Ausgabe 6/2004

Einloggen, um Zugang zu erhalten

Abstract

We review our experiences with forgotten stents and investigate the potential factors determining the degree of encrustation. Our series consists of nine cases of forgotten stent that had remained indwelling for more than 1 year (mean 36.1 months). We describe and compare their various clinical parameters in terms of encrustation. In addition, we briefly summarize our management schemes. All patients showed few stent related irritative symptoms. Six cases showing minimal or no encrustation shared the common feature of urine hypotonicity. Cystoscopic pullout was possible in these cases. The remaining three cases showed moderate to severe encrustation around the stent which required multiple procedures. Pyuria was observed in all cases and two patients had a history of urolithiasis. Finally, all cases were rendered stent and stone free. The fate of forgotten stents was dependent on the amount of encrustation around the stent. In our study, lithogenic history and presence of pyuria were associated with moderate to severe encrustation. Interestingly, patients showing urine hypotonicity tended to have a minimal encrustation on their stents and the stents were easily removed. Therefore, in patients with an impaired renal concentrating ability and a poor medical condition, the duration of indwelling stents might be safely prolonged if the patient has no risk factor for encrustation. As patients with forgotten stents are less likely to complain of stent related symptoms, thorough education of patients is important to prevent stent related complications.
Literatur
1.
Zurück zum Zitat Zimskind PD, Fetter TR, Wilkerson JL (1967) Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol 97: 840PubMed Zimskind PD, Fetter TR, Wilkerson JL (1967) Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol 97: 840PubMed
2.
Zurück zum Zitat Franco G, De Dominicis C, Dal Forno S, Iori F, Laurenti C (1990) The incidence of post-operative urinary tract infection in patients with ureteric stents. Br J Urol 65: 10PubMed Franco G, De Dominicis C, Dal Forno S, Iori F, Laurenti C (1990) The incidence of post-operative urinary tract infection in patients with ureteric stents. Br J Urol 65: 10PubMed
3.
Zurück zum Zitat Mohan-Pillai K, Keeley FXJr, Moussa SA, Smith G, Tolley DA (1999) Endourological management of severely encrusted ureteral stents. J Endourol 13: 377PubMed Mohan-Pillai K, Keeley FXJr, Moussa SA, Smith G, Tolley DA (1999) Endourological management of severely encrusted ureteral stents. J Endourol 13: 377PubMed
4.
Zurück zum Zitat Monga M, Klein E, Castaneda-Zuniga WR, Thomas R (1995) The forgotten indwelling ureteral stent: a urological dilemma. J Urol 153: 1817CrossRefPubMed Monga M, Klein E, Castaneda-Zuniga WR, Thomas R (1995) The forgotten indwelling ureteral stent: a urological dilemma. J Urol 153: 1817CrossRefPubMed
5.
Zurück zum Zitat Borboroglu PG, Kane CJ (2000) Current management of severely encrusted ureteral stents with a large associated stone burden. J Urol 164: 648CrossRefPubMed Borboroglu PG, Kane CJ (2000) Current management of severely encrusted ureteral stents with a large associated stone burden. J Urol 164: 648CrossRefPubMed
6.
Zurück zum Zitat Singh I, Gupta NP, Hemal AK, Aron M, Seth A, Dogra PN (2001) Severely encrusted polyurethane ureteral stents: management and analysis of potential risk factors. Urology 58: 526CrossRefPubMed Singh I, Gupta NP, Hemal AK, Aron M, Seth A, Dogra PN (2001) Severely encrusted polyurethane ureteral stents: management and analysis of potential risk factors. Urology 58: 526CrossRefPubMed
7.
Zurück zum Zitat Somers WJ (1986) Management of forgotten or retained indwelling ureteral stents. Urology 47: 431CrossRef Somers WJ (1986) Management of forgotten or retained indwelling ureteral stents. Urology 47: 431CrossRef
8.
Zurück zum Zitat Reid G, Denstedt JD, Kang YS, Lam D, Nause C (1992) Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo. J Urol 148: 1592PubMed Reid G, Denstedt JD, Kang YS, Lam D, Nause C (1992) Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo. J Urol 148: 1592PubMed
9.
Zurück zum Zitat Cormio L, Talja M, Koivusalo A, Makisalo H, Wolff H, Ruutu M (1995) Biocompatibility of various indwelling double-J stents. J Urol 153: 494CrossRefPubMed Cormio L, Talja M, Koivusalo A, Makisalo H, Wolff H, Ruutu M (1995) Biocompatibility of various indwelling double-J stents. J Urol 153: 494CrossRefPubMed
10.
Zurück zum Zitat Keane PF, Bonner MC, Johnston SR, Zafar A, Gorman SP (1994) Characterization of biofilm and encrustation on ureteric stents in vivo. Br J Urol 73: 687PubMed Keane PF, Bonner MC, Johnston SR, Zafar A, Gorman SP (1994) Characterization of biofilm and encrustation on ureteric stents in vivo. Br J Urol 73: 687PubMed
11.
Zurück zum Zitat Kehinde EO, Al-Awadi KA, Tawheed A, Al-Hunayan A, Ali Y, Mahmoud AH (2001) Factors affecting the fate of prolonged forgotten ‘J’ stents. Scand J Urol Nephrol 35: 222CrossRefPubMed Kehinde EO, Al-Awadi KA, Tawheed A, Al-Hunayan A, Ali Y, Mahmoud AH (2001) Factors affecting the fate of prolonged forgotten ‘J’ stents. Scand J Urol Nephrol 35: 222CrossRefPubMed
12.
Zurück zum Zitat Persky L, Lockhart JJ, Karp R, Helal M, Hakki S (1990) The overlooked, retained double J stent. Urology 36: 519PubMed Persky L, Lockhart JJ, Karp R, Helal M, Hakki S (1990) The overlooked, retained double J stent. Urology 36: 519PubMed
13.
Zurück zum Zitat Chitale SV, Scott-Barrett S, Ho ET, Burgess NA (2002) The management of ureteric obstruction secondary to malignant pelvic disease. Clin Radiol 57:1118CrossRefPubMed Chitale SV, Scott-Barrett S, Ho ET, Burgess NA (2002) The management of ureteric obstruction secondary to malignant pelvic disease. Clin Radiol 57:1118CrossRefPubMed
14.
Zurück zum Zitat Auge BK, Preminger GM (2002) Ureteral stents and their use in endourology. Curr Opin Urol 12:217CrossRefPubMed Auge BK, Preminger GM (2002) Ureteral stents and their use in endourology. Curr Opin Urol 12:217CrossRefPubMed
Metadaten
Titel
Clinical features determining the fate of a long-term, indwelling, forgotten double J stents
verfasst von
Kwanjin Park
Seong-Soo Jeon
Hyungkeun Park
Hyeon Hoe Kim
Publikationsdatum
01.12.2004
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 6/2004
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-004-0442-6

Weitere Artikel der Ausgabe 6/2004

Urolithiasis 6/2004 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.